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ABSTRACT  
Object: Cervical cancer of the uterine (CCU) is the first cancer of the genital tract. In Algeria, this cancer remains a real public health problem. 
The diagnosis is still done often with advanced stages which makes the therapeutic results modest and the cost of t he high care. Methodology: 
Our study aims to elucidate the reality of this type of pathology in the region of Sidi Bel Abbes, northwestern Algeria. This retrospective and 
descriptive study was devoted to the epidemiological and clinical analysis of cervical cancer cases over a period of 3 years. Results: This study 
shows that out of a total of 500 smears recorded between (2014-2016) at the Ana-pathology laboratory level in Sidi Bel Abbes, we found that 
230 smears presented precancerous lesions according to a cytological study, atypical squamous cells of undetermined significance (ASC-US: 
were 18%; low-grade squamous intraepithelial lesions (LSIL) were 20%, while high-grade squamous intraepithelial lesions (HSIL) were 8%. 
The results obtained according to the distribution of the patients in relation to the various factors: the most affected age group is late 46-55 
years with a total of 40%; precocious age of 1st report 18-20 years is (38.2%); gestation 4-5 pregnancies and parities 4-5 children with a rate of 
(38.70% and 32.6%) respectively ; the hormonal state in genital activity is estimated at 62.2%; patients on oral contraception  (OC) have a rate 
of 48.9%. Finally, more than half of the patients (57.8%), were able to have a biopsy within three to four months  of the last smear.  
In histology, the presence of a HPV (Human Papilloma Virus) low grade lesion does not predict the evolution of this lesion. Conclusion: HPV can 
be oncogenic or non-oncogenic. it is the oncogenic HPV infection that is the main risk factor for developing a high grade lesion  and cervical 
cancers outside the associated cofactors.  
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INTRODUCTION 
Worldwide, utérine cervix cancer (UCC) is the second 
gynecological cancer in Algeria, with an incidence of 8.7 per 
100,000 women. It accounts for 12.5% of all female cancers 
according to the national survey conducted by the National 
Institute of Public Health in Algeria [1]. It is the fourth 
leading cause of cancer death in women, with 266,000 deaths 
in 2012 [2]. It has been suggested that healthy women are 
more likely to be screened for UCC [3]. Early detection of 
precancerous lesions remains, as a result, the main axis of 
the fight against the disease which must not, therefore, not 
be a death sentence, even in poor countries. Low-cost 
screening tools and low technology exist today, they could 
significantly reduce the burden of cervical cancer deaths in 
these countries [4]. 
Cervical infections with Human Papilloma Virus (HPV) are 
considered as the first cause of UCC [5]. The infection is 
asymptomatic and transient in the vast majority of cases. 
Viruses are eliminated in 80% of cases in 8 to 12 months. In 
the remaining 20% of cases, the infection persists with the 
appearance of lesions which eventually regress to a large 
extent. Patients who can not get rid of called viruses. 
Oncogenes have an increased risk of developing a pre-
invasive lesion or cervical cancer. The different progress 
made in molecular biology has led to the development of 
vaccines and screening tests that could give hope for better 
prevention of invasive cervical cancer. In 2008, Algeria ranks 
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third among Arab countries in terms of prevalence of this 
cancer. The relatively high prevalence of cases in Algeria is 
due to several risk factors [6]. A program to fight against UCC 
has been launched in Algeria since 2001. In this study, we 
conducted an epidemiological and retrospective survey of 
230 UCC cases in this work, the experience at the Sidi Bel 
Abbes  pathology laboratory level, over an extended 03-year 
period from 2014-2016. 
Today, no evaluation of these actions has been made at the 
level of the Sidi Bel Abbes wilaya, thus, it seemed to us 
interesting to carry out a study of the prevalence of cervical 
dysplasias in this region, because of its disposition of a 
developed screening laboratory. 
MATERIALS AND METHODS 
II.1. Study population 
II. Our work consisted of a retrospective study from 2014 
to 2016 on a population of women who visited the 
cervico-vaginal smear screening unit at the Anatomy and 
Pathology Cytology laboratory at SBA. The main 
parameters used were: Age of first report, distribution of 
cytological lesions by age group, parity, , the number of 
smears by people,  the duration between the last smear 
and the biopsy, the appearance of the cervix before the 
smear and histological control. Data was collected based 
on exam records and analysis done on Excel. From this 
material we selected 500 smears, including 140 
inflammatory smears, 230 smears with low and high 
grade squamous lesions; the latter were checked and 
selected for sampling and for a cytological and 
histological study. 
II.2. La Cytologie et la réalisation de FCU (frottis cervico-
utérins) 
Screening smear was unexpectedly performed in unruly 
women presenting at the consultation for any reason of 
gyneco-obstetrics, monitoring a pregnancy, prescribing a 
contraceptive and setting up an intrauterine device. For 
these cases, the smear was performed on any day of the cycle 
except for the menstrual period; each woman received a 
gynecological examination. The external genitalia were 
examined for inflammations, or unusual flow. The 
appearance of the cervix is controlled and all anomalies are 
noted namely, vaginal discharge, inflammatory aspect, 
ulcerations, vesicles, bleeding on contact, neck frankly 
tumoral. We gathered for the period 2014-2015 and 2016 
cervical-uterine smears, performed as part of screening for 
precancerous cervical lesions; they come to us from routine 
consultations with gynecologists and samplers of SBA 
Maternity, Health sectors at the level of wilaya of SBA and 
Private sector. 
The smears are retained with lesions of ASC-US, LSIL, and 
HSIL (Table 1) that are classified according to the Bethesda 
2001 system. 
II.3. The Histology 
Patients with ASC-US, LISL and HSIL smears are referred to 
colposcopy for colposcopic examination and biopsy. Some of 
these patients who presented with special signs such as 
metrorrhagia had staged curettage without colposcopy. After 
the biopsy, the samples are most often fixed with 9% diluted 
formalin. The staining associates a nuclear dye, Harris 
hematoxylin to cytoplasmic dyes, the orange G and the 
polychrome mixture EA₅₀ of Papanicola, or. A macroscopic 
examination and histological analysis were performed in this 
study (nuclei, basophils in purple, acidophilic cytoplasm, 
pink muscles, erythrocytes and collagen). A judgment is 
made on the cell richness and the technical quality of the 
smear. 
 In order to standardize the results, the interpretation was 
made according to the Bethesda 2001 system. 
III. Results and discussions 
III. I. RESULTS 
III.I.1.Results of cytological diagnosis 
Among 500 smears recorded, 140 correspond to 
inflammatory smears and 130 without particularities, 230 
smears bearing precancerous lesions. In our study, we used 
patient records from 2014 to 2016. A qualitative analysis 
was described in terms of percentage ASC-US lesions are 
reactional changes, repair processes or atrophies and other 
lesions, are intraepithelial of indeterminate variable grade. 
In our study, These lesions represent 18% of the cases in our 
series. Figure 1 shows a microscopic observation of ASC-US 
type smears. Regarding low-grade squamous intraepithelial 
lesions (LISL), we find that nearly half of the smears in our 
series, 20% are low-grade squamous intraepithelial lesions. 
Cytology shows the presence of undifferentiated cells and 
intermediate squamous cells with an often homogeneous 
hyper-chromatic nucleus increased in volume (Figure 1). We 
also note the presence of koilocytic cells crumpled retracted 
nucleus surrounded by a clear halo, he cytoplasm presents it 
self as a dense cynophilic or eosinophilic border. This aspect 
of the nucleus is due to the presence of HPV. Results 
obtained for high-grade squamous intraepithelial lesions 
(HSIL), indicate that this type of lesion is a squamous 
intraepithelial squamous epidermoid lesion which 
represents in this study 08% of patients' cases. Figure 1 
shows the cytology of the high-grade lesions which is 
characterized by: the presence of large nucleus relative to 
the rest of the cell which evokes a very high nucleocyclic 
ratio or inverted, eosinophilic, keratinized or basophilic 
cytoplasm, chromatin in coarser granulations often poorly 
distributed, hyper colored marginate or mottée, the nucleoli 
are visible, the nuclear membrane is strongly indented and 
thickened and the well-differentiated forms, often 
keratinizing, indicate dysplastic cells characterized by a 
more abundant cytoplasm and dyskeratosis with fiber cells.
 
Table 1 : Percentage of Cytologic Abnormalities Diagnosed and Classified by Bethesda 2001 System 
Cytology diagnosis 2014 2015 2016 Number de cases Percentage % 
ASC-US 28 41 21 90 18 
LISL 9 31 60 100 20 
HSIL  7 15 18 40 08 
Normal / / / 130 26 
Inflammatory / / / 140 28 
ASC-US: Atypical Malpighian Cells 
LISL: Low-grade intra-epithelial Malpighian lesion 
HSIL: High-guard intra-ethelial Malpigheal Epidermoid Lesion 
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Fig 1: Example of microscopic observation of smear type (A) type (ASC-US), increased volume core 2.5x the size of an 
intermediate cell, slightly dense chromatin, thin nuclear membrane (x200). (B) Low-grade epithelial lesion (LISL), Koycytic 
Cells (arrow) Papinicola (x400). (C) High-grade epithelial lesion (HSIL), (CIN2-CIN3) and HPV-type infection (x400). 
(D)Histological diagnosis of a low-grade intra-epithelial (CIN1) and high-grade malpighelial lesion (CIN2 and CIN3) with HPV-
typeinfection 
ASC-US: Atypical Malpighian Cells 
LISL: Low-grade intra-epithelial Malpighian lesion 
HSIL: High-guard intra-ethelial Malpigheal Epidermoid Lesion 
CIN1: Low-grade intra-epithelial Malpighelial injury. 
CIN2 and CIN3: High-grade intra-epithelial Malpighelial lesion. 
 
III.1.2.Association of patients with respect to different 
parameters 
The distribution of cytology lesions by age group showed 
that the lesions are observed from 26 years old with a 
frequency peak in the age group 46-55 years, afterwards this 
frequency of lesions diminished with age (Table 2). 
In the same age group, we observed that ASC-US lesions 
accounted for 41% of cases, while LSIL accounted for 43% of 
cases. The extreme ages are 25 and 65 years, more than one 
third of the patients are in the age groups 36-45 years and 
46-55 years; it is the most affected age group with a total of 
75 cases,32.61% and 91 cases, or 40%, respectively. Women 
under 35 and over 55 years of age are less represented 
(15.22% -8.26%) according to this study, while patients 
aged over 65 accounted for only 4.35% of cases, or 10 cases 
in total. In all cases, the proportion of patients married 
before or at age 15 and after age 25 is 7% and 6.5%, 
respectively; that of married women aged between 18-20 
and 21-25 years is 38.2% and 36.1% respectively (Table 3). 
According to the hormonal status, more than 50% of women 
are cases in genital activity, the other half of women were 
either peri-menopausal or menopausal at diagnosis. 
The results of pregnancy and parity in our patients show 
that more than 1/3 of patients have 6 or more children. 
Women who are in genital activity and who are generally on 
oral contraception (OC) account for 48.9%, while 17.4% of 
patients have either an intrauterine device (IUD), or local 
contraception (Cl), in 11.8% of patients, the use or not of a 
contraceptive method was not specified. According to our 
results 45.2% of women in a single cervico-vaginal smear in 
their lives, 30.4% have two smears and 6.6% do not give 
precision (NP). 
Regarding the time interval between the last smear and the 
biopsy, more than half of the patients (57.8%) were able to 
have a biopsy within three to four months of the last smear 
(Table 3). Most of the patients had a pathological neck; of 
which 65.6% were an inflammatory cervix, 10.4% of cases, 
women had contact bleeding; and finally, 24% of cases it was 
a clean collar. 
 
 
Table 2: Distribution of patients in relation to the presence of cytological lesions and by age group 
Age  ASC-US LSIL HSIL Average 
≤25 Years 0 0 0 0.00 
26-35 Years 15 14 2 10.33 
36-45 Years 29 31 13 24.33 
46-55 Years 41 43 15 33.00 
56-65 Years 3 10 8 7.00 
≥65 Years 2 2 2 2.00 
ASC-US: Atypical Malpighian Cells 
LISL: Low-grade intra-epithelial Malpighian lesion 
HSIL: High-guard intra-ethelial Malpigheal Epidermoid Lesion 
Inflammation
Non-specific Cells
ASC-US Cells
Koilocyte
Non-specific Cells
Non-specific 
Cells
HSIL Cells
HSIL Cells
ASC-US 
Cells
Koilocyte
A
B C
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Table 3: Distribution in (%) of the patients in relation to the different parameters 
Setting Numbre des cases % 
Age range 
≤25 years 
26-35 years 
36-45 years 
46-55 years 
56-65 years 
≥65 years 
 
00 
35 
75 
91 
19 
10 
 
00 
15.22 
32.61 
39.57 
8.26 
4.35 
1st report age 
≤15 years 
16-17 years 
18-20 years 
21-25 years 
≥25 years 
 
16 
28 
88 
83 
15 
 
7 
12.2 
38.2 
36.1 
6.5 
Hormonal status 
Genital activity 
Perimenopause 
Menopause  
 
143 
54 
33 
 
62,2 
23.5 
14.3 
Gestational 
≤1 
1-3 
4-5 
6-7 
8-9 
≥ 10 
 
2 
62 
89 
35 
33 
09 
 
0.87 
26.96 
38.70 
15.22 
14.35 
3.91 
Contraception 
CO 
DIU 
CL 
Unspecified 
 
70 
25 
17 
31 
 
48.9 
17.4 
11.8 
21.6 
Number smear 
1 
2 
3 
>3 
NP 
 
104 
70 
36 
5 
15 
 
45.2 
30.4 
15.6 
2.2 
6.6 
Time interval 
≤3 
3-4 
5-6 
7-8 
9-12 
≥ 12 
 
62 
133 
20 
8 
7 
0 
 
27 
57.8 
8.7 
3.5 
3 
0 
Cervix aspect 
Healthy 
Inflammatory 
Bleeding  
 
55 
151 
24 
 
24 
65.5 
10.5 
 
III.1.3. Histological control 
For all our patients and whatever the appearance of the 
cervix and the type of abnormalities found in the smear, a 
colposcopic examination with the biopsy was requested. The 
majority of the patients benefited from colposcopy: 07 cases 
or 3% have insufficient samples; 12 cases (5.1%) are 
without particularity; 71 cases (30.9%) have an 
inflammatory, metaplastic, and atrophic or polyp aspect and 
140 cases (60.9%) have HPV-related lesions (Figure 2).The 
cyto-histological concordance concerning our serial and 
evaluated at 90% (screening and colposcopic results with 
biopsy).
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Fig 2: Percentage histological diagnosis (%) patients with different abnormalities. 
 
Regarding low-grade squamous intraepithelial lesion (CIN1), 
the microscopic examination shows an exocervical mucosa 
with a koilocyte surface coating, cellular disorganization 
with the presence of nuclei. While high-grade intraepithelial 
lesions (CIN2 and CIN3), superficial exocervical-coated 
patches are at the level of the surface layer of architectural 
disorganization with a disturbance in cell maturation and 
differentiation that in some places exceeds 2 / 3 of the 
height of the coating with some figures of atypical mitoses 
(Figure 1), presence of koilocytes. 
III.2. DISCUSSIONS 
The study covered 500 smears during 03 years (2014-2016). 
In this work, we selected 230 cervico-vaginal smears (CVS) 
with pre-cancerous lesions. We remind that in general, the 
woman only presents herself after one or more pregnancies. 
90.4% of women do not know the importance of CVS 
according to the [7] study. 
 The majority of benign cellular changes such as the ASC-US 
case; nevertheless, 5 to 17% of high-grade intraepithelial 
lesions are found according to [8], the ASC-H group 
comprises approximately 50 to 80% of high-grade 
intraepithelial lesions [9]. In difficult cases, the cyto-
pathologist proposes either to repeat the smear test 
estrogen, hormone replacement impregnation mitigates 
trophic cell damage, to better distinguish dystrophic 
changes, lesion changes, or to colposcopy.According to the 
distribution of cytological lesions by age group. 
In our series a single peak of HPV cytological lesions was 
found between 46 and 55 years of age (Table 2); in the 
literature, there is little study on the age distribution of HPV-
related cytological lesions. 
The woman only consults for the first smear after the 
marriage, usually well after the first pregnancy. In our series, 
among women whose age range is between 26 and 65 years 
old, low-grade cytological abnormalities regress frequently 
and decrease after this age, and the high-grade cytological 
abnormalities correspond to 20% of the cases in our series. 
In the study of [7], indicate that 95.5% of women have the 
first smear from age 40, our results may be biased by late 
consultation for smear practice. Age plays an important role 
for most authors. 
 In the study [10], the most represented age group is 46 and 
over with 37.9%, the 36-45 age group represented 34.7% 
and 25-35 years, 27.4%, with extreme 25 to 87 years old. 
The average age of diagnosis is 54 years according to the 
Directorate General of Health Structures in Algeria (DGSSA), 
2016. The occurrence of metrorrhagia caused by sexual 
intercourse or the vaginal toilet must evoke a cervical lesion. 
Sometimes cancer of the cervix is revealed by leucorrhea 
associated with blood. We have found from our series (Table 
3) that patients with cervical lesions are women who are 
married for the most part after 16 years (peak between 18-
20 years) or 38.2%. The distribution of women by age is an 
important factor, where the influence of age at first report 
on the risk of acquisition of HPV infection and consequently 
the risk of developing high-grade lesions and of cancer that 
have been regularly cited in several works.  
The adolescent's cervix is both more exposed to infections 
and more vulnerable because of the physiological eversion 
of the glandular mucosa (monolayer epithelium more 
exposed to the gaps allowing the entry of the virus). 
According to the study conducted by [11] found a marked 
precocity to marriage, as 62.3% are married before the age 
of 17, a study conducted in Burkina Faso reports 63.80% of 
early marriage to 16 years or earlier, we find that women 
who had their first relationship between 15 and 17 years 
have a risk doubled according to the study conducted by 
[12] .The analysis according to [7] showed a three-fold 
higher risk among married women between 18 and 20 years 
old. In the case of the distribution of women by pregnancy 
and parity, we found in this study (Table 3) that 32.6% of 
patients are multiparous (4-5 pregnancies or more), the 
nulliparous rate is ≤ at 2.2%, whereas, [7], found in its series 
of 209 cases of CCU, a high risk in women with 7 or more 
children. 
His findings found against the literature of [13], that 
multiparous women had a fourfold higher risk of developing 
squamous lesions. The large multiparity linked to a large 
multi-Gestity appears as a risk factor. 
0
50
100
150
200
250
300
N
u
m
b
e
r
o
f 
ca
se
s 
an
d
 p
e
rc
e
n
ta
ge
histological diagnosis
Histological diagnosis
nomberof cases
%
Meziani et al                                                                                                           Journal of Drug Delivery & Therapeutics. 2020; 10(1-s):72-78 
ISSN: 2250-1177                                                                                  [77]                                                                                 CODEN (USA): JDDTAO 
Some authors consider it a co-factor related to uncontrolled 
sexual activity or unplanned maternity. An epidemiological 
survey conducted under the auspices of the World Health 
Organization (WHO) attributes to oral contraception for 
more than 8 years a risk of cervical cancer multiplied by 2.2. 
For intraepithelial lesions, the effect appears to be less 
important, even nil or protective [14]. Another study 
considers that gestationality is a risk factor in its own right, 
implying the physiological repercussions of the evolution of 
pregnancy. on the mechanisms of local immune defenses 
linked to the biological upheaval experienced by the cervical 
epithelium [15]. Relative risk in women who have completed 
07 or more Pregnancies. Concerning choice of contraception 
(Table 3), he results showed that 48.9% of the women are in 
genital activity and have a lesion smear that has been under 
oral contraception. 
The duration of contraception has not been evaluated. The 
choice of the contraceptive method also seems to affect the 
risk of CCU. The barrier-type method seems to reduce the 
risks, while oral contraceptives seem to increase it. The risk 
associated with oral contraceptives seems to be greater for 
adenocarcinoma than for squamous cell carcinoma, even 
after adjusting for different socio-economic and sexual 
factors [16]. More than 50%, that is to say 65% of patients 
under oral contraception of which 62% since more than 05 
years according to [17]; and a duration of four to eight years 
for women have a rate of 45.5% or 31.5% with oral 
contraception. [7]. A meta-analysis of 24 international 
epidemiological studies confirms a total of 52,000 women, 
an association between taking oral contraceptives and 
precancerous lesions or invasive cancer. This study shows 
that the risk of cancer increases with the duration of use of 
the pill, a relative risk of 1.9 for a catch of at least 05 years 
compared to those that have never been used. The results 
obtained on the hormonal state parameter (Table 3) and a 
precancerous lesion showed that more than 50% of women 
are cases in genital activity, 
the other half of women are either peri-menopausal or 
menopausal. His women accounted for 40.7% in their series; 
and among them the invasive cancer was found in 75.0% 
according to a study conducted by [10]. Regarding the 
appearance of the cervix smear, the results show that in our 
series (Table 3) most of the patients had a pathological neck; 
in 65.6% it was an inflammatory cervix. The foul-smelling 
leucorrhea and scratch-off lesions that are evidence of 
genital infection are described as a co-risk factor for cervical 
cancer in their chronic appearance, and they were reported 
proportionally by 84.7% and 58.1% of their studies, and 
who had a high LEL, unlike invasive cancer, which was 
relatively more common among women who did not report 
this history [10]. In our study almost half (45.2%) had a 
single cervico-vaginal smear. The international 
recommendations specify that the first smear must be done 
one year after the first sexual intercourse, the second to one 
year later in the absence of anomaly. This recommendation 
is based on the very slow evolution of precancerous lesions 
and statistical models show that smears performed every 
three years allow the detection of 93% of CCU. For that, a 
biopsy is necessary to evaluate the risk of the beginning of 
cancer. According to our study conducted on 230 cases, or 
57.8% having the biopsy in a duration of 3-4 months of the 
last smear, this allowed to have the image more or less exact 
of the lesion without it being modified by evolution in time. 
n this case, colposcopic control is mandatory in the event of 
an ASC-US, LISL and HISL abnormal smear, which must be 
done before 6 months, also before LISL and when the chosen 
option is colposcopy the practice of the latter must not 
exceed 6 months [18]. Colposcopy has interested sexually 
active women from the age of 20, with a predominance of 
women over 50 years old. . Cervical cancer screening should 
be offered to all sexually active women from the age of 20 
[12; 19]. We have been able in most cases to respect the time 
interval of less than 06 months between the last smear and 
the biopsy. 
Finally the histological diagnosis manages to select a rate of 
8% of high-grade lesions, 1.3% infiltrating cancers and 
38.6% low-grade lesions; testifying on the one hand of the 
good application of the cytological criteria of LSIL of the 
Bethesda system, on the other hand cytology is relatively 
easy LSIL.In Algeria, Women with LISL lesions are most 
often controlled by initial colposcopy when possible. 
Moreover, LISL and as we have seen in the literature can 
hide high-grade lesions or invasive carcinomas, the control 
of all LISLs by colposcopy with or without histology makes it 
possible to identify these high-grade lesions and to avoid the 
risk of evading follow-up, but this can weigh heavily 
economically and time. 
Specificity is also increased by the combination of the HPV 
test. On can be seen from our results that cytological 
abnormalities regress frequently and decrease with age, 
which explains why the incidence of HPV infections 
decreases with the age of women. 
CONCLUSION 
The Cervical Cancer in the Uterine (CCU) is probably the 
cancer whose screening would be the most contributive if it 
were conducted under favorable conditions. While everyone 
recognizes the legitimacy of this screening and its 
effectiveness, the terms of its organization for mass 
screening still create differences. At the end of our study, it 
seems clear that the conventional smear remains the only 
weapon to detect cervical cancer at its beginning. to 
introduce a treatment that is not or not mutilating and thus 
ensure the highest possible survival rate. Visual inspection 
methods are simple, inexpensive, and therefore affordable 
for developing countries; to effectively detect precancerous 
lesions of the cervix. Colposcopy is the key examination of 
the diagnosis of high-grade cervical lesions; it guides 
biopsies by locating the most suspect areas of cancer. 
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